Prevalence of precancerous and other metaplasia in the distal oesophagus and gastro-oesophageal junction

References

• Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825–31
   PubMed Web of Science ®Google Scholar
• Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130: 883–90
   PubMed Web of Science ®Google Scholar
• Lagergren J, Bergstrom R, Adami HO, Nyren O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 2000; 133: 165–75
   PubMed Web of Science ®Google Scholar
• Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857–9
   PubMed Web of Science ®Google Scholar
• Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997; 92: 212–5
   PubMed Web of Science ®Google Scholar
• van der Burgh A, Dees J, Hop WC, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996; 39: 5–8
   PubMed Web of Science ®Google Scholar
• Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992; 102: 1212–9
   PubMed Web of Science ®Google Scholar
• Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus: the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998; 93: 1033–6
   PubMed Web of Science ®Google Scholar
• Falk GW. Barrett's esophagus. Gastroenterology 2002; 122: 1569–91
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 2000; 119: 333–8
   PubMed Web of Science ®Google Scholar
• Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997; 26: 487–94
   PubMed Web of Science ®Google Scholar
• Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277–85
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994; 344(8936)1533–6
   PubMed Web of Science ®Google Scholar
• Wolf C, Seldenrijk CA, Timmer R, Breumelhof R, Smout AJ. Epidemiological, clinical, and histological characteristics of intestinal metaplasia at the oesophagogastric junction compared to short segments of columnar-lined oesophagus. Eur J Gastroenterol Hepatol 2001; 13: 113–20
   PubMed Web of Science ®Google Scholar
• Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461–7
   PubMed Web of Science ®Google Scholar
• Mantynen T, Farkkila M, Kunnamo I, Mecklin JP, Juhola M, Voutilainen M. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants. Am J Gastroenterol 2002; 97: 2524–9
   PubMed Web of Science ®Google Scholar
• Johnston MH, Hammond AS, Laskin W, Jones DM. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1996; 91: 1507–11
   PubMed Web of Science ®Google Scholar
• Voutilainen M, Farkkila M, Juhola M, Mecklin JP, Sipponen P. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis. Gut 1999; 45: 644–8
   PubMed Web of Science ®Google Scholar
• Nandurkar S, Talley NJ, Martin CJ, Ng TH, Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 1997; 40: 710–5
   PubMed Web of Science ®Google Scholar
• Krishnamurthy S, Dayal Y. Pancreatic metaplasia in Barrett's esophagus. An immunohistochemical study. Am J Surg Pathol 1995; 19: 1172–80
   PubMed Web of Science ®Google Scholar
• Wang HH, Zeroogian JM, Spechler SJ, Goyal RK, Antonioli DA. Prevalence and significance of pancreatic acinar metaplasia at the gastroesophageal junction. Am J Surg Pathol 1996; 20: 1507–10
   PubMed Web of Science ®Google Scholar
• Polkowski W, van Lanschot JJ, ten Kate FJ, Rolf TM, Polak M, Tytgat GN, et al. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus. Am J Gastroenterol 2000; 95: 617–25
   PubMed Web of Science ®Google Scholar
• Chandrasoma PT, Der R, Ma Y, Dalton P, Taira M. Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 2000; 24: 402–9
   PubMed Web of Science ®Google Scholar
• Miller LS. Endoscopy of the esophagus. The esophagus, DO Castell. Little, Brown & Co., Boston 1992; 89–142
   Google Scholar
• Macdonald CE, Wicks AC, Playford RJ. Ten years’ experience of screening patients with Barrett's oesophagus in a university teaching hospital. Gut 1997; 41: 303–7
   PubMed Web of Science ®Google Scholar
• Glickman JN, Wang H, Das KM, Goyal RK, Spechler SJ, Antonioli D, et al. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol 2001; 25: 87–94
   PubMed Web of Science ®Google Scholar
• Kilgore SP, Ormsby AH, Gramlich TL, Rice TW, Richter JE, Falk GW, et al. The gastric cardia: fact or fiction?. Am J Gastroenterol 2000; 95: 921–4
   PubMed Web of Science ®Google Scholar